Effects of COX-2 Inhibition on Uveal Melanoma Cells
Author Information
Author(s): Marshall Jean-Claude, Caissie Amanda L, Cruess Stephanie R, Cools-Lartigue Jonathan, Burnier Miguel N Jr
Primary Institution: The Henry C. Witelson Ocular Pathology Laboratory and Registry, McGill University
Hypothesis
This study aimed to investigate the effect of a COX-2 inhibitor on the proliferation rate of human uveal melanoma cells and its effect on macrophage nitric oxide production.
Conclusion
Amfenac affected both COX-2 transfected and non-transfected uveal melanoma cells in terms of their proliferation rates and their suppressive effects on macrophage cytotoxic activity.
Supporting Evidence
- Cells transfected to express COX-2 had a higher proliferation rate than those that did not.
- The addition of Amfenac significantly decreased the proliferation rate of all cell lines.
- Nitric oxide production by macrophages was inhibited by the addition of melanoma conditioned medium.
Takeaway
The study found that a drug called amfenac can slow down the growth of certain eye cancer cells and help immune cells work better.
Methodology
Human uveal melanoma cell lines were transfected to express COX-2, and their proliferation rates were measured with and without the addition of amfenac. Nitric oxide production by macrophages was also measured after exposure to melanoma-conditioned medium.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website